Recordati Reports 8.8% EBITDA Growth in H1 2026 Despite Currency Headwinds
Key Facts
Amid a period of steady demand in the healthcare sector, Recordati reported solid financial performance for the first half of 2026. According to reports, consolidated net revenue reached €1,410.8 million, marking a 6.6% increase compared to the previous period. The company's EBITDA rose by 8.8% to reach €540.2 million, which represents 38.3% of its net revenue.
The growth was primarily driven by continued momentum in the group's core business segments, which achieved a 9.1% increase when measured at constant exchange rates. However, these gains were partially offset by a negative currency impact totaling €34.5 million during the first half of the year. Adjusted net income also saw an upward trajectory, growing by 6.7% to reach €349.9 million.
Investors are monitoring the company's ability to maintain margin expansion in the face of ongoing currency volatility. Future catalysts will depend on the group's ability to sustain its core segment momentum and mitigate foreign exchange risks.